๐ฐ Immunization Practices News
Page 115 - Immunization Practices News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Immunization Practices. Real-time updates on events, politics, business and more.
April 20, 2023
The CDC will be taking steps to simplify COVID-19 vaccine recommendations and allow more flexibility for people at higher risk who want added protection from additional COVID-19 vaccine doses
April 20, 2023
The agency said that people at higher risk -- such as the immunocompromised and those over age 65 -- could choose to get a second booster shot before this fall.
April 20, 2023
On March 29, 2023, the Departments of Labor (โDOLโ), Health and Human Services (โHHSโ), and Treasury (the โDepartmentsโ) published FAQs Part 58 on the Families First Coronavirus...
April 20, 2023
The agency does call whatโs coming to a transition to traditional health care coverage. It says many Americans will continue to pay nothing out-of-pocket for the COVID-19 vaccine.
April 20, 2023
Employers, may have some relief from some of the Affordable Care Act requirements to cover preventive care services without cost sharing under a nationwide injunction issued March 30, 2023, by a federal judge in Texas, ruling affects only the services and screening USPSTF
April 20, 2023
Following FDA regulatory action, CDC has taken steps to simplify COVID-19 vaccine recommendations and allow more flexibility for people at higher risk who want the option of added protection from additional COVID-19 vaccine doses.
April 20, 2023
The Centers for Disease Control and Prevention (CDC) said on April 19 that older people and people with ...
April 20, 2023
Employers, at least for now, may have some relief from some of the Affordable Care Act (ACA) requirements to cover preventive care services without cost sharing under a nationwide...
April 20, 2023
No objection to updated recommendations from ACIP members, but concern over certain gaps
April 20, 2023
The CDC updated and simplified its vaccine recommendations on April 19, 2023, and the Moderna and Pfizer-BioNTech mRNA bivalent COVID-19 vaccines should be used for all vaccinations in the US.